| Brooke Campbell, LPC | |
|
115 N Church St Ste 1, Moorestown, NJ 08057-2493 | |
| (856) 200-8203 | |
| Not Available |
| Full Name | Brooke Campbell |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 115 N Church St Ste 1, Moorestown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003492521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 37PC00736600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Campbell, LPC 115 N Church St Ste 1, Moorestown, NJ 08057-2493 Ph: (856) 200-8203 | Brooke Campbell, LPC 115 N Church St Ste 1, Moorestown, NJ 08057-2493 Ph: (856) 200-8203 |
News Archive
Practices used in policing injection drug users in Russia might contribute to HIV transmission and overdose mortality.
A very aggressive disease with a poor prognosis, gallbladder cancer may be connected to higher exposure to estrogens, according to a group of researchers at the University of Houston (UH). Dr. Jan-ke Gustafsson, Robert A. Welch Professor in UH's biology and biochemistry department, described his team's findings in a paper titled "Estrogen-dependent gallbladder carcinogenesis in LXRβ-/- female mice" appearing in a recent issue of the journal Proceedings of the National Academy of Sciences, one of the world's most-cited multidisciplinary scientific serials.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA), with a goal date of March 26, 2012 under the Prescription Drug User Fee Act (PDUFA).
This report, published by the Center for Strategic & International Studies (CSIS) on Monday and titled "Righting the Global Fund," recounts the adversity faced by the Geneva-based Global Fund to Fight AIDS, Tuberculosis, and Malaria over the course of 2011 and suggests potential strategies for addressing these challenges going forward.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
› Verified 1 days ago
Ms. Natasha Elisabeth Horsley, M.S., L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 E Main St Ste 1a, Moorestown, NJ 08057 Phone: 856-220-3394 Fax: 856-727-1715 | |
Paula Sherry, LPC Counselor Medicare: Medicare Enrolled Practice Location: 300 Harper Dr, Moorestown, NJ 08057 Phone: 856-380-1070 Fax: 856-552-1315 | |
Ms. Terese Catherine Hall, MA, BC-DMT, LPC Counselor Medicare: Medicare Enrolled Practice Location: 720 E Main St, Suite 1a, Moorestown, NJ 08057 Phone: 856-722-9043 Fax: 856-727-1715 | |
Mikaela M. Morcombe, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 740 Marne Hwy Ste 108, Moorestown, NJ 08057 Phone: 732-982-2888 | |
Brianna Bliss, LPC Counselor Medicare: Medicare Enrolled Practice Location: 128 Bortons Landing Rd, Moorestown, NJ 08057 Phone: 856-780-6293 | |
Mr. John Joseph Blum, LPC, LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 74 E 2nd St, 2nd Floor, Moorestown, NJ 08057 Phone: 856-304-2469 Fax: 856-608-1809 |